Meta Pixel

News and Announcements

Cure Brain Cancer Foundation – CEO Interview

  • Published October 29, 2014 12:20PM UTC
  • Publisher Wholesale Investor
  • Categories Executive Interviews

Cure Brain Cancer Foundation is the largest dedicated funder of brain cancer research in Australia. Partnering with the research community, we are steering the national agenda for brain cancer research. Our mission is to accelerate new treatments to brain cancer patients and increase five-year survival to 50% within 10 years. Our priorities are to:

  • Bring together global brain cancer stakeholders to set and agree priorities and gain consensus for the Australian research component globally and locally.
  • Identify and short-list research projects on the basis of their compatibility with the CBCF research strategy.

To find out more about Cure Brain Cancer Foundation please listen to CEO, Ms Catherine Stace.

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now